Neuroblastoma is a malignant type of tumour that occurs in childhood. Approximately 20-25 children are diagnosed with Neuroblastoma annually in the Netherlands. Kathelijne Kraal’s research focuses on optimising the use of a particular form of targeted radiotherapy for patients with neuroblastoma, including those with intraspinal extension.
K.C.J.M. Kraal: Optimising Therapy with 131I-MIBG for Neuroblastoma Patients and for Neuroblastoma Patients with Intraspinal Extension.
Prof. H.N. Caron
Dr G.A.M. Tytgat
Dr M.M. van Noesel (Universiteit Utrecht)
This event is open to the public.